Pfizer ABRYSVO® Post-Authorisation Safety Study – Pregnancy

RSV MAH-funded study Safety ABRYSVO®
Back to studies

Ongoing study

The purpose of this study is to assess the safety profile of the Pfizer RSV vaccine in women who receive the vaccine during pregnancy and their offspring.